PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Mejia, Analilia [D-NJ-11]

Rep. Mejia, Analilia [D-NJ-11]

United States · Official source

Records

105 records where Rep. Mejia, Analilia [D-NJ-11] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9745 (119th)referred

Orlin’s Law

United States · United States Congress · 16 July 2026

Bill· HRH.R. 9432 (119th)referred

LIFT the BAR Act

United States · United States Congress · 24 June 2026

Bill· HRH.R. 9210 (119th)referred

BLANCHE Act of 2026

United States · United States Congress · 9 June 2026

Resolution· HCONRESH.Con.Res. 108 (119th)passed

Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from hostilities in Lebanon.

United States · United States Congress · 3 June 2026

This concurrent resolution directs the President to remove U.S. Armed Forces from hostilities in Lebanon within seven days of the resolution's adoption. The resolution specifies that it shall not be construed to prevent or limit security cooperation with the Lebanese Armed Forces or the protection of diplomatic facilities.

Resolution· HCONRESH.Con.Res. 103 (119th)referred

Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran.

United States · United States Congress · 20 May 2026

This concurrent resolution directs the President to remove U.S. Armed Forces from hostilities against Iran unless explicitly authorized by a declaration of war or a congressional authorization for use of military force against Iran. Elements of the U.S. Armed Forces needed to defend the United States, an ally, or a partner from imminent attack are not covered by this requirement provided the President complies with a specified provision of the War Powers Resolution. (The provision generally requires the President to remove U.S. Armed Forces from hostilities no more than 60 days after the President notifies or is required to notify Congress of such involvement, unless Congress authorizes such use. For more information on the War Powers Resolution, see  CRS In Focus 13134 .)

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 7802 (119th)referred

DISCLOSE Act of 2026

United States · United States Congress · 4 March 2026

Democracy Is Strengthened by Casting Light On Spending in Elections Act of 2026 or the DISCLOSE Act of 2026 This bill addresses campaign finance, including by expanding the prohibition on campaign spending by foreign nationals, requiring additional disclosures of campaign expenditures, and requiring additional disclosures regarding certain political advertisements. Specifically, the bill expands existing foreign money prohibitions to include disbursements for paid web-based or digital communications and federal judicial nomination communications. It also prohibits foreign nationals from contributing to campaigns related to ballot initiatives and referenda. The Government Accountability Office must, for each four-year election cycle, study and report on the incidence of illicit foreign money in federal elections. Next, the bill makes it unlawful to establish or use a corporation, company, or other entity with the intent to conceal an election contribution or donation by a foreign national. A violator is subject to criminal penalties—a fine, a prison term of up to five years, or both. Covered organizations (e.g., corporations, labor organizations, and political organizations) must, within 24 hours, file reports with the Federal Election Commission to disclose campaign expenditures of more than $10,000 during an election cycle. The bill also requires organizations to provide additional disclosures regarding political advertisements, including the donors who contributed the most money to that organization in the last year.

Bill· HRH.R. 7531 (119th)referred

Healthy Families Act

United States · United States Congress · 12 February 2026